Masayoshi Suda

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Venues

Nature aging

Cells

Endocrine reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Goro Katsuumi, Ippei Shimizu, Masayoshi Suda, Yohko Yoshida, Takaaki Furihata, Yusuke Joki, Chieh-Lun Hsiao, Liang Jiaqi, Shinya Fujiki, Manabu Abe, Masataka Sugimoto, Tomoyoshi Soga, Tohru Minamino
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature aging 4 (7) (2024)
Goro Katsuumi, Ippei Shimizu, Masayoshi Suda, Yohko Yoshida, Takaaki Furihata, Yusuke Joki, Chieh-Lun Hsiao, Liang Jiaqi, Shinya Fujiki, Manabu Abe, Masataka Sugimoto, Tomoyoshi Soga, Tohru Minamino
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature aging (2024)
Goro Katsuumi, Ippei Shimizu, Masayoshi Suda, Yohko Yoshida, Takaaki Furihata, Yusuke Joki, Chieh-Lun Hsiao, Liang Jiaqi, Shinya Fujiki, Manabu Abe, Masataka Sugimoto, Tomoyoshi Soga, Tohru Minamino
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature aging 4 (7) (2024)
Goro Katsuumi, Ippei Shimizu, Masayoshi Suda, Yohko Yoshida, Takaaki Furihata, Yusuke Joki, Chieh-Lun Hsiao, Liang Jiaqi, Shinya Fujiki, Manabu Abe, Masataka Sugimoto, Tomoyoshi Soga, Tohru Minamino
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature aging 4 (7) (2024)
Goro Katsuumi, Ippei Shimizu, Masayoshi Suda, Yohko Yoshida, Takaaki Furihata, Yusuke Joki, Chieh-Lun Hsiao, Liang Jiaqi, Shinya Fujiki, Manabu Abe, Masataka Sugimoto, Tomoyoshi Soga, Tohru Minamino
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature aging (2024)
Goro Katsuumi, Ippei Shimizu, Masayoshi Suda, Yohko Yoshida, Takaaki Furihata, Yusuke Joki, Chieh-Lun Hsiao, Liang Jiaqi, Shinya Fujiki, Manabu Abe, Masataka Sugimoto, Tomoyoshi Soga, Tohru Minamino
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature aging (2024)
Goro Katsuumi, Ippei Shimizu, Masayoshi Suda, Yohko Yoshida, Takaaki Furihata, Yusuke Joki, Chieh-Lun Hsiao, Liang Jiaqi, Shinya Fujiki, Manabu Abe, Masataka Sugimoto, Tomoyoshi Soga, Tohru Minamino
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature aging 4 (7) (2024)
Masayoshi Suda, Karl H Paul, Utkarsh Tripathi, Tohru Minamino, Tamara Tchkonia, James L Kirkland
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction. Endocrine reviews (2024)
Masayoshi Suda, Karl H Paul, Tohru Minamino, Jordan D Miller, Amir Lerman, Georgina M Ellison-Hughes, Tamar Tchkonia, James L Kirkland
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. Cells 12 (9) (2023)
Masayoshi Suda, Karl H Paul, Tohru Minamino, Jordan D Miller, Amir Lerman, Georgina M Ellison-Hughes, Tamar Tchkonia, James L Kirkland
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. Cells 12 (9) (2023)
Masayoshi Suda, Karl H Paul, Tohru Minamino, Jordan D Miller, Amir Lerman, Georgina M Ellison-Hughes, Tamar Tchkonia, James L Kirkland
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. Cells 12 (9) (2023)

Masayoshi Suda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masayoshi Suda